Managed Healthcare Executive February 26, 2024
Participation in the program will not be a prerequisite for GLP-1 prescriptions.
CarelonRx, the pharmacy benefit manager for Elevance Health, announced that it will launch a digital weight management program for its self-insured customers this spring, joining the list of payers looking for ways to cope with the escalating demand for weight loss services fueled by the popularity of the GLP-1 drugs, Wegovy (semaglutide) and Zepbound (tirzepatide).
The company said yesterday that participation in the program will not be required for a GLP-1 prescription and that clients will be able to offer the program independently from coverage of Wegovy and Zepbound.
“At CarelonRx, we want to ease the complexities of weight loss and weight management and support healthier lifestyles for...
Today's Sponsors
Today's Sponsor